Mohammad A Al-Mamun1, Todd Brothers1,2, Andrea Sikora Newsome3. 1. University of Rhode Island, Kingston, RI, USA. 2. Roger Williams Medical Center, Providence, RI, USA. 3. The University of Georgia College of Pharmacy, Augusta, GA, USA.
Abstract
INTRODUCTION: The Medication Regimen Complexity -Intensive Care Unit (MRC-ICU) is the first tool for measuring medication regimen complexity in critically ill patients. This study tested machine learning (ML) models to investigate the relationship between medication regimen complexity and patient outcomes. METHODS: This study was a single-center, retrospective observational evaluation of 130 adults admitted to the medical ICU. The MRC-ICU score was utilized to improve the inpatient model's prediction accuracy. Three models were proposed: model I, demographic data without medication data; model II, demographic data and medication regimen complexity variables; and model III: demographic data and the MRC-ICU score. A total of 6 ML classifiers was developed: k-nearest neighbor (KNN), naïve Bayes (NB), random forest, support vector machine, neural network, and logistic classifier (LC). They were developed and tested using electronic health record data to predict inpatient mortality. RESULTS: The results demonstrated that adding medication regimen complexity variables (model II) and the MRC-ICU score (model III) improved inpatient mortality prediction.. The LC outperformed the other classifiers (KNN and NB), with an overall accuracy of 83%, sensitivity (Se) of 87%, specificity of 67%, positive predictive value of 93%, and negative predictive value of 46%. The APACHE III score and the MRC-ICU score at the 24-hour interval were the 2 most important variables. CONCLUSION AND RELEVANCE: Inclusion of the MRC-ICU score improved the prediction of patient outcomes on the previously established APACHE III score. This novel, proof-of-concept methodology shows promise for future application of the MRC-ICU scoring tool for patient outcome predictions.
INTRODUCTION: The Medication Regimen Complexity -Intensive Care Unit (MRC-ICU) is the first tool for measuring medication regimen complexity in critically ill patients. This study tested machine learning (ML) models to investigate the relationship between medication regimen complexity and patient outcomes. METHODS: This study was a single-center, retrospective observational evaluation of 130 adults admitted to the medical ICU. The MRC-ICU score was utilized to improve the inpatient model's prediction accuracy. Three models were proposed: model I, demographic data without medication data; model II, demographic data and medication regimen complexity variables; and model III: demographic data and the MRC-ICU score. A total of 6 ML classifiers was developed: k-nearest neighbor (KNN), naïve Bayes (NB), random forest, support vector machine, neural network, and logistic classifier (LC). They were developed and tested using electronic health record data to predict inpatient mortality. RESULTS: The results demonstrated that adding medication regimen complexity variables (model II) and the MRC-ICU score (model III) improved inpatient mortality prediction.. The LC outperformed the other classifiers (KNN and NB), with an overall accuracy of 83%, sensitivity (Se) of 87%, specificity of 67%, positive predictive value of 93%, and negative predictive value of 46%. The APACHE III score and the MRC-ICU score at the 24-hour interval were the 2 most important variables. CONCLUSION AND RELEVANCE: Inclusion of the MRC-ICU score improved the prediction of patient outcomes on the previously established APACHE III score. This novel, proof-of-concept methodology shows promise for future application of the MRC-ICU scoring tool for patient outcome predictions.
Entities:
Keywords:
administration; clinical pharmacy; clinical practice; critical care; medical informatics
Authors: Shamim Nemati; Andre Holder; Fereshteh Razmi; Matthew D Stanley; Gari D Clifford; Timothy G Buchman Journal: Crit Care Med Date: 2018-04 Impact factor: 7.598
Authors: Heather M Giannini; Jennifer C Ginestra; Corey Chivers; Michael Draugelis; Asaf Hanish; William D Schweickert; Barry D Fuchs; Laurie Meadows; Michael Lynch; Patrick J Donnelly; Kimberly Pavan; Neil O Fishman; C William Hanson; Craig A Umscheid Journal: Crit Care Med Date: 2019-11 Impact factor: 7.598
Authors: Robert P Granko; Lindsey B Poppe; Scott W Savage; Rowell Daniels; Edwin A Smith; Peter Leese Journal: Am J Health Syst Pharm Date: 2012-08-15 Impact factor: 2.637
Authors: Ben Wellner; Joan Grand; Elizabeth Canzone; Matt Coarr; Patrick W Brady; Jeffrey Simmons; Eric Kirkendall; Nathan Dean; Monica Kleinman; Peter Sylvester Journal: JMIR Med Inform Date: 2017-11-22
Authors: Christopher J McWilliams; Daniel J Lawson; Raul Santos-Rodriguez; Iain D Gilchrist; Alan Champneys; Timothy H Gould; Mathew Jc Thomas; Christopher P Bourdeaux Journal: BMJ Open Date: 2019-03-07 Impact factor: 2.692
Authors: Rahul Kumar Sevakula; Wan-Tai M Au-Yeung; Jagmeet P Singh; E Kevin Heist; Eric M Isselbacher; Antonis A Armoundas Journal: J Am Heart Assoc Date: 2020-02-13 Impact factor: 5.501
Authors: Mohammad A Al-Mamun; Jacob Strock; Yushuf Sharker; Khaled Shawwa; Rebecca Schmidt; Douglas Slain; Ankit Sakhuja; Todd N Brothers Journal: J Clin Med Date: 2022-08-11 Impact factor: 4.964